Penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus
- PMID: 25044998
- PMCID: PMC4236225
- DOI: 10.1002/iub.1289
Penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus
Abstract
High-level resistance to β-lactam antibiotics in methicillin-resistant Staphylococcus aureus (MRSA) is due to expression of penicillin-binding protein 2a (PBP2a), a transpeptidase that catalyzes cell-wall crosslinking in the face of the challenge by β-lactam antibiotics. The activity of this protein is regulated by allostery at a site 60 Å distant from the active site, where crosslinking of cell wall takes place. This review discusses the state of knowledge on this important enzyme of cell-wall biosynthesis in MRSA.
Keywords: allosteric regulation; conformational change; methicillin-resistant Staphylococcus aureus; resistance mechanism; β-lactam antibiotics.
© 2014 International Union of Biochemistry and Molecular Biology.
Figures
References
-
- Jevons MP. Celbenin resistant staphylococci. BMJ. 1961;1:124–125.
-
- Walsh C. Deconstructing vancomycin. Science. 1999;284:442–443. - PubMed
-
- French GL. Bactericidal agents in the treatment of MRSA infections--the potential role of daptomycin. J. Antimicrob. Chemother. 2006;58:1107–1117. - PubMed
-
- Wilcox MH. Update on linezolid: The first oxazolidinone antibiotic. Expert Opin. Pharmacother. 2005;6:2315–2326. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
